Positron Emission Tomography (PET) Amyloid Imaging of the Brain in Healthy Young Adult Subjects

Phase 3 Completed 218 enrolled GE Healthcare Medpace, Inc. · collab i3 Statprobe · collab

Non-randomizedSingle-groupOpen-labelDiagnostic

Summary

Amyloid is an abnormal chemical found in the brain of patients with Alzheimer's Disease (AD). The study drug helps produce pictures of amyloid in the brain. The purpose of this study is to determine how well the study drug performs in young healthy subjects.

Timeline

Start: 2010-12
Primary completion: 2011-03
Completion: 2011-04

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Flutemetamol	Diagnostic / imaging agent	185 mbq	Intravenous

Indications

No indication recorded.